Decongestant on the aging radar: oxymetazoline eyed as anti-aging clue
Researchers at Northeastern University screened 6,442 drugs and found that oxymetazoline, the active ingredient in Afrin, could improve intercellular communication, a hallmark of aging, suggesting a potential pathway for anti-aging therapies. Human trials don’t exist yet and scientists caution this is early-stage research, not a cure for aging. The piece also notes the drug’s habit-forming nature and mentions aspirin as another drug touching several aging hallmarks, underscoring that further work in cells, animals, and eventually people is needed.
